Aficamten Advancing for Cardiomyopathy After SEQUOIA-HCM
The investigational oral drug leads to "clinically meaningful" improvements in obstructive hypertrophic cardiomyopathy, a pivotal trial shows.
Source: medscape.com
Stay updated with breaking news from Stever Ommen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The investigational oral drug leads to "clinically meaningful" improvements in obstructive hypertrophic cardiomyopathy, a pivotal trial shows.